Market Research Report
North America Dietary Supplements Market Forecast 2019-2028
|Published by||Inkwood Research||Product code||980908|
|Published||Content info||155 Pages
Delivery time: 2-3 business days
|North America Dietary Supplements Market Forecast 2019-2028|
|Published: January 11, 2021||Content info: 155 Pages||
The North America dietary supplements market growth is set to evolve at a CAGR of 9.73% during the forecast period, 2019-2028. The growing awareness regarding nutritional enrichment and the high adoption of herbal medicines are among the primary drivers of market growth in the region.
Canada and the United States are assessed for the North America dietary supplements market growth analysis. Canada has stringent national health regulations regarding nutritional supplements. The growing baby-boomer population and health awareness among adults promote market growth in Canada, along with the rising usage of dietary supplements by the aging population. Anti-aging and vitality supplements are projected to be in high demand. Nutritional supplement usage is more common among adults aged 19 and above. The CR Jamieson brand continues to be the largest brand of dietary supplements in Canada, trailed by Valeant Pharmaceuticals. The geriatric population, surging awareness about self-care, and product innovations are set to propel the demand for dietary supplements. The aging population primarily drives the growth of probiotic and protein supplements. Moreover, shifting preferences have resulted in the increased growth of herbal dietary supplements.
Some of the prominent companies in the market include, Glanbia Plc, GlaxoSmithKline Plc, Pfizer, Herbalife Ltd, Bayer AG, Abbott Laboratories, etc.